Während die Wirkung der meisten gebräuchlichen Antibiotika auf einer Beeinträchtigung wichtiger bakterieller Prozesse beruht, wirken manche Substanzen durch die Störung der Zellmembran-Struktur. Da Fettsäuren ein essentieller Bestandteil von Membran-Phospholipiden sind, stellt die bakterielle Fettsäurebiosynthese II (FAS-II) einen relativ wenig erforschten, aber dennoch vielversprechenden Angriffspunkt für die Entwicklung neuer Antibiotika dar. Das wichtige Antituberkulotikum Isoniazid blockiert die mykobakterielle Fettsäurebiosynthese und ruft dadurch morphologische Änderungen sowie letztlich die Lyse des Bakteriums hervor. Eine wichtige Erkenntnis war, dass Isoniazid den letzten Schritt des FAS-II Elongationszyklus inhibiert, der durch die Enoyl-ACP Reduktase katalysiert wird. Darauf aufbauend wurden mehrere Programme ins Leben gerufen, die sich zum Ziel gesetzt hatten, neue Moleküle zu entwickeln, welche dieses Protein verschiedener Pathogene hemmen. Die S. aureus Enoyl-ACP Reduktase (saFabI) ist von besonders großem Interesse, da drei vielversprechende Inhibitoren dieses Proteins entwickelt werden konnten, die momentan in klinischen Studien eingehend untersucht werden. Trotz dieser Erfolgsaussichten waren zum Zeitpunkt, als die vorliegenden Arbeiten aufgenommen wurden, keine Kristallstrukturen von saFabI öffentlich verfügbar. Daher war es eines der Hauptziele dieser Doktorarbeit, auf der Basis von kristallographischen Experimenten atomar aufgelöste Modelle für dieses wichtige Protein zu erzeugen. Durch die Entwicklung einer verlässlichen Methode zur Kristallisation von saFabI im Komplex mit NADP+ und Diphenylether-Inhibitoren konnten Kristallstrukturen von 17 verschiedenen ternären Komplexen gelöst werden. Weitere kristallographische Experimente ergaben zwei apo-Strukturen sowie zwei Strukturen von saFabI im Komplex mit NADPH und 2-Pyridon-Inhibitoren. Basierend auf der nun bekannten saFabI-Struktur konnten Molekulardynamik-Simulationen durchgeführt werden, um zusätzliche Erkenntnisse über die Flexibilität dieses Proteins zu erhalten. Die so gewonnenen Informationen über die Struktur und Beweglichkeit des Enzyms dienten in Folge als ideale Grundlage dafür, den Erkennungsprozess von Substrat und Inhibitor zu verstehen. Besonders bemerkenswert dabei ist, dass die verschiedenen saFabI Kristallstrukturen Momentaufnahmen entlang der Reaktionskoordinate der Ligandenbindung und des Hydrid-Transfers repräsentieren. Dabei verschließt der so genannte Substratbindungsloop das aktive Zentrum des Enzyms allmählich. Die außergewöhnlich hohe Mobilität von saFabI konnte durch molekulardynamische Simulationen bestätigt werden. Dies legt nahe, dass die beobachteten Änderungen der Konformation tatsächlich an der Aufnahme und Umsetzung des Substrates beteiligt sind. Eine Kette von Wassermolekülen zwischen dem aktiven Zentrum und einer wassergefüllten Kavität im Inneren des Tetramers scheint für die Beweglichkeit des Substratbindungsloops und somit für die katalysierte Reaktion von entscheidender Bedeutung zu sein. Außerdem wurde die erstaunliche Beobachtung gemacht, dass der adaptive Substratbindungsprozess mit einem Dimer-Tetramer Übergang gekoppelt ist, welcher die beobachtete positive Kooperativität der Ligandenbindung erklären kann. Alles in allem weist saFabI im Vergleich zu FabI Proteinen aus anderen Organismen mehrere außergewöhnliche Eigenschaften auf, die für die Synthese von verzweigten Fettsäuren nötig sein könnten, welche wiederum für die Überlebensfähigkeit von S. aureus im Wirt von Bedeutung sind. Diese Erkenntnis könnte erklären, warum S. aureus selbst bei Anwesenheit von exogenen Fettsäuren von FAS-II Inhibitoren abgetötet werden kann. Somit können die gewonnenen atomaren saFabI Modelle einen entscheidenden Beitrag zur Entwicklung neuer Hemmstoffe dieses validierten Angriffszieles leisten. Tatsächlich konnten die neuen Strukturen genutzt werden, um die Bindungsstärken sowie die Verweilzeiten verschiedener saFabI Inhibitoren molekular zu erklären. Die Struktur von saFabI im Komplex mit dem 2-Pyridon Inhibitor CG400549 hingegen enthüllte spezifische Wechselwirkungen in der geweiteten Bindetasche des S. aureus Enzyms, welche das geringe Aktivitätsspektrum dieses derzeit klinisch erprobten Inhibitors erklären. Diese Studien schaffen somit eine ideale Voraussetzung für die Entwicklung neuer wirksamer saFabI Inhibitoren, was am Beispiel des 4-Pyridons PT166 belegt werden kann. Im Rahmen der vorliegenden Dissertation konnten außerdem die Strukturen des Enzyms KasA im Komplex mit mehreren Derivaten des Naturstoffs Thiolactomycin gelöst werden. / Whereas most currently used antibiotics act by interfering with essential bacterial processes, a smaller group of antibacterials disturbs the integrity of the cell membrane. Since fatty acids are a vital component of membrane phospholipids, the type-II fatty acid biosynthesis pathway (FAS-II) of bacteria constitutes a promising drug target. The front-line anti-tuberculosis prodrug isoniazid blocks the FAS-II pathway in M. tuberculosis thereby leading to morphological changes and finally to cell lysis. When it became evident that the enoyl-ACP reductase in the FAS-II pathway is the target of the activated isoniazid, several programs were initiated to develop novel inhibitors directed against this protein in different pathogens. The S. aureus enoyl-ACP reductase (saFabI) is of particular interest since three promising drug candidates inhibiting this homologue have reached clinical trials. However, despite these prospects, no crystal structures of saFabI were publicly available at the time the present work was initiated. Thus, one major goal of this thesis was the generation of high-resolution atomic models by means of X-ray crystallography. The development of a highly reproducible approach to co-crystallize saFabI in complex with NADP+ and diphenyl ether-based inhibitors led to crystal structures of 17 different ternary complexes. Additional crystallographic experiments permitted the view into two apo-structures and two atomic models of saFabI in complex with NADPH and 2-pyridone inhibitors. Based on the established saFabI structure, molecular dynamics (MD) simulations were performed to improve our understanding of the conformational mobility of this protein. Taken together, these investigations of the saFabI structure and its flexibility served as an ideal platform to address important questions surrounding substrate and inhibitor recognition by this enzyme. Intriguingly, our saFabI structures provide several vastly different snapshots along the reaction coordinate of ligand binding and hydride transfer, including the closure of the flexible substrate binding loop (SBL). The extraordinary mobility of saFabI was confirmed by MD simulations suggesting that conformational motions indeed play a pivotal role during substrate delivery and turnover. A water chain linking the active site with a water-basin inside the homo-tetrameric enzyme was found likely to be crucial for the closure and opening of the SBL and, thus, for the catalyzed reaction. Notably, the induced-fit ligand binding process involves a dimer-tetramer transition, which could be related to the observed positive cooperativity of cofactor and substrate binding. Overall, saFabI displays several unique characteristics compared to FabI proteins from other organisms that might be necessary for the synthesis of branched-chain fatty acids, which in turn are required for S. aureus fitness in vivo. This finding may explain why S. aureus is sensitive to FAS-II inhibitors even in the presence of exogenous fatty acids. Accordingly, saFabI remains a valid drug target and our structures can be used as a molecular basis for rational drug design efforts. In fact, binding affinity trends of diphenyl ether inhibitors and, more importantly, the correlated residence times could be rationalized at the molecular level. Furthermore, the structure of saFabI in complex with the 2-pyridone inhibitor CG400549 revealed unique interactions in the wider binding crevice of saFabI compared to other FabI homologues explaining the narrow activity spectrum of this clinical candidate with proven human efficacy. In summary, these studies provide an ideal platform for the development of new, effective saFabI inhibitors as exemplified by the promising 4-pyridone PT166. In the context of this dissertation, crystal structures of the condensing enzyme KasA in complex with several analogs of the naturally occurring inhibitor thiolactomycin have been solved.

No description available.

No description available.

Abstract not available

<p>The aim of the present study was to investigate the biosynthesis of the ATP synthase in various tissues, and to test hypotheses about possible models of activation of several mitochondrial proteins, the ATP/ADP translocase and UCPs, that could utilize the proton gradient, thus bypassing the ATP synthase. </p><p>We have examined the role of the expression of the P1 isoform of the c-F_o subunit in the biogenesis of ATP synthase in brown adipose tissue. Our findings point to a role for the c-F_o subunit in defining the final content of the ATP synthase in brown adipose tissue.</p><p>We have analyzed sequences in the 3’UTR of the β subunit F₁-ATPase mRNA that are important for formation of RNA-protein complexes. We could detect protein complexes that bind to two different sequence regions of the 3’UTR, one being the poly(A) tail and an adjacent region), and the other being a sequence stretch at the 3’ end of the 3’UTR able to form a stem-loop structure, which is evolutionarily conserved throughout mammalian species. </p><p>We investigated a role of the ATP/ADP carrier (ANT) in fatty acid-induced uncoupling in brown-fat mitochondria. We conclude that the ANT cannot substitute for UCP1 in fatty acid uncoupling in brown-fat mitochondria from mice lacking UCP1. We propose that the two ANT isoforms mediate proton translocation under different conditions.</p><p>We have investigated a role of UCP1 in defence against oxidative stress. We found that products of oxidative stress (4-HNE) could neither reactivate purine nucleotide-inhibited UCP1, nor induce additional activation of innately active UCP1 in brown-fat mitochondria from UCP1(+/+) and UCP1(-/-) mice. We conclude that UCP1 is not involved in defence against oxidative stress. </p><p>We evaluated possible uncoupling activity of UCP3 in skeletal muscle from warm- and cold-acclimated UCP1(+/+) and UCP1(-/-) mice. We conclude that no evidence exists for a higher UCP3-mediated uncoupling activity; a high UCP3 content in cold-acclimated UCP1(-/-) mice could possibly be linked to improved fatty acid oxidative capacity.</p>

<p>This master’s thesis deals with studies of lateral and vertical carrier transport Dot-in- </p><p>a-Well (DWELL) Quantum Dot Infrared Photodetectors (QDIPs). During the pro ject, </p><p>devices have been developed and tested using a Fourier Transform Infrared (FTIR) spec- </p><p>trometer with the purpose to find the processes governing the flow of photocurrent in </p><p>the different kinds of detectors, the dark current magnitude in the vertical Quantum Dot </p><p>Infrared Photodetector (QDIP) and the Quantum Well Infrared Photodetector (QWIP) </p><p>and the light polarization dependences for the vertical QDIP and the QWIP. </p><p>The lateral carrier transport DWELL QDIP was found to have poor conduction </p><p>in the well mainly due to re-trapping of electrons in this region. The main process gov- </p><p>erning the flow of photocurrent for this type of device at 77K is photo-excitation from </p><p>the Quantum Dot (QD)s to the excited state in the Quantum Well (QW) and further </p><p>thermal excitation. If the electrons are mainly transported in the matrix or the well at </p><p>77K is presently not clear. </p><p>For the vertical carrier transport DWELL QDIP at 77K, the wavelength response </p><p>could be tuned by altering the applied voltage. At higher voltages, the dominant process </p><p>was found to be photo-excitation from the QDs to the excited state in the QW followed </p><p>by thermal assisted tunneling into the GaAs-matrix. At lower voltages, photo-excitation </p><p>from the QDs directly into the the GaAs-matrix was the predominant process. The dark </p><p>current level in the vertical QDIPs was found to be 1.5 to 5 orders of magnitude smaller </p><p>than for the QWIP measured at 77K. Furthermore, the QDIP was found to be close to </p><p>polarization independent. As expected the QWIP had a reduced sensitivity to normal </p><p>incident light. The existence of this signal was attributed to interface scattering of light </p><p>inside the device.</p>

The haemolymph of the adult Colorado potato beetle, Lepinotarsa decemlineata Say, contains a high molecular weight (MW > 200,000) JH-III specific binding protein. The Kd value of the protein for racemic JH-III is 1.3 ± 0.2 × 10−7 M. It has a lower affinity for racemic JH-I and it does not bind JH-III-diol or JH-III-acid. The binding protein does discriminate between the enantiomers of synthetic, racemic JH-III as was determined by stereochemical anaysis of the bound and the free JH-III. Incubation of racemic JH-III with crude haemolymph results in preferential formation of (10S)-JH-III-acid, the unnatural configuration. The JH-esterase present in L. decemlineata haemolymph is not enantioselective. It is concluded that the most important function of the binding protein is that of a specific carrier, protecting the natural hormone against degradation by esterases. The carrier does not protect JH-I as efficiently as the lower homologue.

Coherent detection employing multilevel modulation formats has become one of the most promising technologies for next generation high speed transmission systems due to the high power and spectral efficiencies. Using the powerful digital signal processing (DSP), coherent optical receivers allow the significant equalization of chromatic dispersion (CD), polarization mode dispersion (PMD), phase noise (PN) and nonlinear effects in the electrical domain. Recently, the realizations of these DSP algorithms for mitigating the channel distortions in the coherent transmission systems are the most attractive investigations. The CD equalization can be performed by the digital filters developed in the time and the frequency domain, which can suppress the fiber dispersion effectively. The PMD compensation is usually performed in the time domain with the adaptive least mean square (LMS) and constant modulus algorithms (CMA) equalization. Feed-forward and feed-back carrier phase estimation (CPE) algorithms are employed to mitigate the phase noise (PN) from the transmitter (TX) and the local oscillator (LO) lasers. The fiber nonlinearities are compensated by using the digital backward propagation methods based on solving the nonlinear Schrödinger (NLS) equation and the Manakov equation. In this dissertation, we present a comparative analysis of three digital filters for chromatic dispersion compensation, a comparative evaluation of different carrier phase estimation methods considering digital equalization enhanced phase noise (EEPN) and a brief discussion for PMD adaptive equalization. To implement these investigations, a 112-Gbit/s non-return-to-zero polarization division multiplexed quadrature phase shift keying (NRZ-PDM-QPSK) coherent transmission system with post-compensation of dispersion is realized in the VPI simulation platform. In the coherent transmission system, these CD equalizers have been compared by evaluating their applicability for different fiber lengths, their usability for dispersion perturbations and their computational complexity. The carrier phase estimation using the one-tap normalized LMS (NLMS) filter, the differential detection, the block-average (BA) algorithm and the Viterbi-Viterbi (VV) algorithm is evaluated, and the analytical predictions are compared to the numerical simulations. Meanwhile, the phase noise mitigation using the radio frequency (RF) pilot tone is also investigated in a 56-Gbit/s NRZ single polarization QPSK (NRZ-SP-QPSK) coherent transmission system with post-compensation of chromatic dispersion. Besides, a 56-Gbit/s NRZ-SP-QPSK coherent transmission system with CD pre-distortion is also implemented to analyze the influence of equalization enhanced phase noise in more detail. / QC 20120528

The aim of the present study was to investigate the biosynthesis of the ATP synthase in various tissues, and to test hypotheses about possible models of activation of several mitochondrial proteins, the ATP/ADP translocase and UCPs, that could utilize the proton gradient, thus bypassing the ATP synthase. We have examined the role of the expression of the P1 isoform of the c-Fo subunit in the biogenesis of ATP synthase in brown adipose tissue. Our findings point to a role for the c-Fo subunit in defining the final content of the ATP synthase in brown adipose tissue. We have analyzed sequences in the 3’UTR of the β subunit F1-ATPase mRNA that are important for formation of RNA-protein complexes. We could detect protein complexes that bind to two different sequence regions of the 3’UTR, one being the poly(A) tail and an adjacent region), and the other being a sequence stretch at the 3’ end of the 3’UTR able to form a stem-loop structure, which is evolutionarily conserved throughout mammalian species. We investigated a role of the ATP/ADP carrier (ANT) in fatty acid-induced uncoupling in brown-fat mitochondria. We conclude that the ANT cannot substitute for UCP1 in fatty acid uncoupling in brown-fat mitochondria from mice lacking UCP1. We propose that the two ANT isoforms mediate proton translocation under different conditions. We have investigated a role of UCP1 in defence against oxidative stress. We found that products of oxidative stress (4-HNE) could neither reactivate purine nucleotide-inhibited UCP1, nor induce additional activation of innately active UCP1 in brown-fat mitochondria from UCP1(+/+) and UCP1(-/-) mice. We conclude that UCP1 is not involved in defence against oxidative stress. We evaluated possible uncoupling activity of UCP3 in skeletal muscle from warm- and cold-acclimated UCP1(+/+) and UCP1(-/-) mice. We conclude that no evidence exists for a higher UCP3-mediated uncoupling activity; a high UCP3 content in cold-acclimated UCP1(-/-) mice could possibly be linked to improved fatty acid oxidative capacity.

This thesis mainly presents the design and implementation of a flyback converter with single-stage power factor correction. In the beginning, we propose different power factor collection (PFC) techniques referring to the inductor current of converter under three kinds of operation modes. In the continuous mode, we adopt the nonlinear-carrier control (NLC). Then, in the discontinuous mode and boundary mode, voltage-follower control (VFC) and transition mode technique control (TM) are adopted respectively. As to the converter analysis, we derive and verify the results of a small-signal model and perform equivalent circuit analysis by state-space averaging method, loss-free resistor (LFR) model, averaging method for two-time-scale system (AM), and current injected equivalent circuit approach (CIECA). Results derived from the above-mentioned models are compared and verified to be accurate of the system model. Furthermore, the control function and element design are implemented by simulation. We perform a PI controller to achieve better power factor based on results of analysis of the time and frequency domains analysis. Finally, three sets of different hardware are fabricated and verified depending on measured result and theoretical simulation.